Merit Medical Systems Inc (MMSI) stock
MMSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/309% below fair value
$84.49−1.86 (-2.15%)
Close on Nov 17, 2026Market cap $5.06BP/E 31.8Yield –
Merit Medical Systems r&d expenses
Research and development expenses are spending on new products and technology.
Merit Medical Systems's R&D Expenses for the twelve months ending Sep 30, 2026 was $96.93M, up 1.0% year over year. For fiscal 2025 it was $97.35M, up 11.3% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $97.35M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.35M | +11.3% |
| FY2024 | Dec 31, 2024 | $87.47M | +5.7% |
| FY2023 | Dec 31, 2023 | $82.73M | +9.6% |
| FY2022 | Dec 31, 2022 | $75.51M | +6.0% |
| FY2021 | Dec 31, 2021 | $71.25M | +23.8% |
| FY2020 | Dec 31, 2020 | $57.54M | -12.3% |
| FY2019 | Dec 31, 2019 | $65.62M | +10.2% |
| FY2018 | Dec 31, 2018 | $59.53M | +15.8% |
| FY2017 | Dec 31, 2017 | $51.40M | +13.7% |
| FY2016 | Dec 31, 2016 | $45.23M | +10.8% |
| FY2015 | Dec 31, 2015 | $40.81M | +11.4% |
| FY2014 | Dec 31, 2014 | $36.63M | +8.1% |
| FY2013 | Dec 31, 2013 | $33.89M | +21.9% |
| FY2012 | Dec 31, 2012 | $27.80M | +26.7% |
| FY2011 | Dec 31, 2011 | $21.94M | +43.1% |
| FY2010 | Dec 31, 2010 | $15.34M | +37.3% |
| FY2009 | Dec 31, 2009 | $11.17M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $22.39M | -6.6% |
| Q2 FY2026 | Jun 30, 2026 | $25.39M | +4.2% |
| Q1 FY2026 | Mar 31, 2026 | $22.61M | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | $26.54M | +5.3% |
| Q3 FY2025 | Sep 30, 2025 | $23.97M | +16.8% |
| Q2 FY2025 | Jun 30, 2025 | $24.37M | +20.3% |
| Q1 FY2025 | Mar 31, 2025 | $22.48M | +4.6% |
| Q4 FY2024 | Dec 31, 2024 | $25.19M | +16.4% |
| Q3 FY2024 | Sep 30, 2024 | $20.53M | +4.5% |
| Q2 FY2024 | Jun 30, 2024 | $20.26M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | $21.48M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | $21.64M | +5.9% |
| Q3 FY2023 | Sep 30, 2023 | $19.65M | +2.2% |
| Q2 FY2023 | Jun 30, 2023 | $20.13M | +9.0% |
| Q1 FY2023 | Mar 31, 2023 | $21.31M | +22.6% |
| Q4 FY2022 | Dec 31, 2022 | $20.44M | +0.1% |
| Q3 FY2022 | Sep 30, 2022 | $19.22M | +13.2% |
| Q2 FY2022 | Jun 30, 2022 | $18.47M | +5.0% |
| Q1 FY2022 | Mar 31, 2022 | $17.39M | +6.8% |
| Q4 FY2021 | Dec 31, 2021 | $20.41M | +34.8% |
| Q3 FY2021 | Sep 30, 2021 | $16.97M | +25.7% |
| Q2 FY2021 | Jun 30, 2021 | $17.59M | +25.4% |
| Q1 FY2021 | Mar 31, 2021 | $16.27M | +9.4% |
| Q4 FY2020 | Dec 31, 2020 | $15.13M | -6.9% |
| Q3 FY2020 | Sep 30, 2020 | $13.51M | -20.5% |
| Q2 FY2020 | Jun 30, 2020 | $14.03M | -14.1% |
| Q1 FY2020 | Mar 31, 2020 | $14.87M | -7.3% |
| Q4 FY2019 | Dec 31, 2019 | $16.25M | +5.8% |
| Q3 FY2019 | Sep 30, 2019 | $16.99M | +17.0% |
| Q2 FY2019 | Jun 30, 2019 | $16.33M | +6.6% |
| Q1 FY2019 | Mar 31, 2019 | $16.04M | +12.0% |
| Q4 FY2018 | Dec 31, 2018 | $15.37M | +20.8% |
| Q3 FY2018 | Sep 30, 2018 | $14.53M | +13.1% |
| Q2 FY2018 | Jun 30, 2018 | $15.32M | +15.0% |
| Q1 FY2018 | Mar 31, 2018 | $14.32M | +14.3% |
| Q4 FY2017 | Dec 31, 2017 | $12.73M | +8.0% |
| Q3 FY2017 | Sep 30, 2017 | $12.84M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.79M | – |
See a number that looks wrong?